Mesoblast (ASX:MSB) Delivers 60% Jump in Ryoncil Sales, Strengthening Commercial Momentum

January 9, 2026

Mesoblast Lifts on Ryoncil Growth Mesoblast (ASX:MSB) delivered a very strong performance this morning following a positive guidance update for…

Codan (ASX:CDA) Takes Off, 30% Rally on Strong Half-Year Update

January 9, 2026

Codan Finds Its Signal Over the past week, Codan Limited (ASX:CDA) has surged by around 30%. For a company with…

Cochlear (ASX:COH) is still a long term growth story you should listen to

January 9, 2026

Cochlear is one of few stocks that has created immense shareholder value and has also greatly improved the lives of…

Lithium in 2026: Here is Why The Next Bull Market Is Beginning Now, And 5 ASX Lithium Stocks to Consider!

January 9, 2026

Lithium in 2026 could be the biggest roller-coaster we’ve seen since the pandemic. Even though battery technology and everything it…

Duratec (ASX: DUR) Surges on AUKUS Contract Progress: Is This Defence Stock a Buy?

January 9, 2026

Duratec Poised for Growth with AUKUS Contracts Duratec (ASX: DUR) has quietly become one of the standout performers in Australia’s…

Monadelphous (ASX:MND) Hits All-Time High on $535m BHP and Rio Tinto Contracts: Buy or Take Profits?

January 9, 2026

Monadelphous  Hits Record High on $535m Contracts Monadelphous (ASX: MND) surged to an all-time high of A$28.89 this week after…

Canyon Resources (ASX:CAY) Surges 7% as Cameroon Bauxite Mine Nears Production: Time to Buy?

January 9, 2026

Canyon Resources Targets Bauxite Production by 2026 Canyon Resources (ASX: CAY) is gaining strong momentum as the company approaches a…

Ansell (ASX:ANN) Drops 6% on CEO Exit: Is This a Buying Opportunity?

January 9, 2026

Is Ansell’s CEO Change a Hidden Opportunity for Investors? Ansell (ASX: ANN) fell over 6% on Thursday after announcing that…

Anthropic Raising US$10B at US$350B Valuation, Led by GIC and Coatue

January 8, 2026

Anthropic Raising $10bn at US$350bn valuation Anthropic is completing a US$10 billion funding round at an implied valuation of around…

Alcidion (ASX:ALC) Surges 15% After Winning Preferred Supplier Role for A$35M NHS Contract

January 8, 2026

Alcidion Secures Preferred Supplier Status for Major UK EPR System Worth Over A$35M Alcidion shares rose 15% today following a…

Elsight (ASX:ELS) Breaks New Ground, A$682K US Order Marks First Civilian Contract Win

January 8, 2026

From Battlefield to Main Street Elsight (ASX:ELS) has secured its first commercial order in calendar year 2026 from a US…

When “Fast” Breaks: A Simple Explanation of Settlement, Holds, and Delays

January 8, 2026

When people say they want payments to be “fast,” what they usually mean is “predictable.” If the app says approved,…

The Dogs of the Dow (or ASX) Strategy: Should Investors Consider It?

January 8, 2026

As investors consider their strategies for 2026, The Dogs of the Dow (or ASX) strategy could be one of them.…

Novo Nordisk (CPH: NOVO-B): It’s not all smooth sailing for the US$180bn company behind obesity drug Ozempic

January 8, 2026

Not many 100-year old healthcare stocks see a sudden 30% jump in sales in one year and become the largest…

Greatland Resources (ASX:GGP) Hits Record High as Cash Surges to $948m – Buy, Hold or Sell?

January 8, 2026

Greatland Resources Hits Record High on Strong Cash Flow Greatland Resources (ASX: GGP) hit a new record high of A$11.6…